SlideShare a Scribd company logo
RNA Processing
KRVS Chaitanya
Messenger RNA (mRNA) and its region
• Messenger RNA operates as the template for protein
synthesis.
• Messenger RNA encodes genetic information from DNA as a
transcript and translates the information to a ribosome and
helps assemble amino acids in their proper order.
• mRNA is directly transcribed from DNA, whereas in case of
eukaryotes, a pre-mRNA is first transcribed from DNA and
then processed to yield mature mRNA.
Three main regions occur in both prokaryotic and
eukaryotic mRNAs.
1. 5’ UTR:
•The 5′ untranslated region (5′ UTR; also called the
leader) is a nucleotide sequence at the 5′ end of the
mRNA that does not encode any of amino acids.
•In bacterial mRNA, this region consists of the
consensus sequence termed as the Shine-Dalgarno
sequence.
•During translation, Shine-Dalgarno sequence
serves as a ribosome binding site. This sequence is
found approximately seven nucleotides upstream of
the first codon that is translated into the amino acid,
also termed as start codon.
•In its 5′ untranslated region, eukaryotic mRNA has
no equivalent consensus sequence.
•Ribosomes bind to a modified 5′ end of mRNA in
eukaryotic cells.
2. Protein coding region:
•The next section of mRNA is the protein-coding
region, containing the codons that describe the
protein’s amino acid sequence.
•The protein-coding region starts with a start codon
and terminates with a stop codon.
3. 3’ UTR:
•The 3′ untranslated region (trailer), a nucleotide
sequence at the3′ end of the mRNA, is the last
mRNA region and not translated into protein.
•The 3′ UTR affects mRNA stability and the
translation of the protein-coding sequence of the
mRNA.
Post-transcriptional modification in
Eukaryotes
• Transcription and translation take place concurrently in
bacterial cells; when the 3′ end of an mRNA is undergoing
transcription, ribosomes bind near the 5′ end to the Shine-
Dalgarno sequence and begin translation.
• Since transcription and translation are coupled, before
protein synthesis, bacterial mRNA has little opportunity to be
changed.
• In contrast, in eukaryotic cells, transcription and translation
are segregated both in time and space.
•In the nucleus, transcription takes place while
translation takes place in the cytoplasm; this
separation offers a chance to modify eukaryotic RNA
before translating it.
•Indeed, after transcription, eukaryotic mRNA is
altered extensively.
•Changes are made to the RNA molecule’s 5′ end, the 3′
end, and protein coding portion.
•Following are the examples of Post-transcriptional
modification:
1. The 5 ‘Cap Addition:
• One type of eukaryotic pre-mRNA modification is the addition of a
structure called a 5 ‘cap at its 5’end.
• At the 5’ end of the mRNA, the cap consists of an additional
nucleotide and methyl groups (CH3) at the base of one or more
nucleotides at the 5′ end of the newly inserted nucleotide and the 2′-
OH group of sugar.
• After transcription initiation, the insertion of the cap takes place
quickly.
• It is possible to represent the 5′ end of pre-mRNA as 5′-pppNpNpN, in
which a ribonucleotide is represented by the letter ‘N‘ and a
phosphate by ‘p‘.
• One of these phosphate groups is removed shortly
after the start of transcription and a guanine
nucleotide is added.
• A special 5′-5′ bond connects this guanine nucleotide
to the pre mRNA, which is somewhat different from the
normal 5′-3′ phosphodiester bond that binds all the
other RNA nucleotides.
• To the 5′ end, one or more methyl groups are added.
• The first of these methyl groups is attached to the
position 7 of the base of the terminal guanine
nucleotide making the base 7-methyl guanine.
• Next, in the second and third nucleotides, a methyl
group may be attached to the 2′ position of the sugar.
• Additional methyl groups can rarely be attached to the
bases of the second and third nucleotides of pre-
mRNA.
2. The Poly A tail addition:
• The addition of 50 to 250 or more adenine nucleotides at the 3′
end, forming a poly(A) tail, is a second kind of modification to
eukaryotic mRNA.
• These nucleotides are not encoded in the DNA, but are inserted
in a process called polyadenylation following transcription.
• Many RNA polymerase II transcribed eukaryotic genes are
transcribed well past the end of the coding sequence; much of
the extra material is then cleaved at the3′ end and the poly(A)
tail is inserted.
•Sequences both upstream and downstream of the cleavage
site are necessary for processing the3′ end of pre-mRNA.
•Generally, downstream of the cleavage site is a sequence
rich in uracil nucleotides.
•On many mRNAs, the poly(A) tail confers stability,
increasing the time during which the mRNA remains
intact and available for translation.
•The poly(A) tail also enhances the ribosome’s attachment
to the mRNA.
3. RNA splicing:
• The removal of introns by RNA splicing is the other
major type of eukaryotic pre-mRNA modification.
• Before the RNA moves to the cytoplasm, this
modification takes place in the nucleus.
• The presence of three sequences in the intron is
required for splicing.
•One end of the intron is referred to as the 5′ splice site,
and the other end is the 3′ splice site.
•Most introns begin with GU in pre-mRNAs and end with
AG.
•The third sequence that is necessary for splicing is
present at the branch point, which is an adenine
nucleotide that is situated 18-40 nucleotides upstream of
the 3′ splice site.
• Splicing occurs within a large structure called the
spliceosome, which is one of the largest and most
complex of all molecular complexes.
• Five RNA molecules (U1, U2, U4, U5, and U6) and
almost 300 proteins form the spliceosome.
• Small nuclear RNAs (snRNAs) ranging in length from
107 to 210 nucleotides are the RNA components; these
snRNAs are associated with proteins to form small
particles of ribonucleoprotein.
Process of RNA splicing:
• An intron is between an upstream exon (exon1) and a
downstream exon (exon 2) before splicing takes place.
• In two distinct stages, pre-mRNA is spliced.
• The pre-mRNA is cut at the 5 ‘splice site in the first
stage of splicing.
• This cut frees exon 1 from the intron, and the intron’s
5′ end connects to the branch point; that is, the intron
folds back on itself, creating a structure called a lariat.
• In this reaction, via a trans-esterification reaction, the
guanine nucleotide in the consensus sequence at the 5′
splice site binds with the adenine nucleotide at the
branch stage.
• To the cytoplasm, where it is translated, the mature
mRNA consisting of the exons spliced together is
exported.
• A cut is made at the3′ splice site in the second step of
RNA splicing and, simultaneously, the3′ end of exon 1
is covalently connected (spliced) to the5′ end of exon
2.
• It releases the intron as a lariat.
• When the bond splits at the branch stage, the intron
becomes linear and is then quickly degraded by
nuclear enzymes.
• To the cytoplasm, where it is translated, the mature
mRNA consisting of the exons spliced together is
exported.
Alternative processing pathways for RNA
splicing:
• In order to generate alternative forms of mRNA, a single pre-
mRNA is processed in various ways, resulting in the
development of various proteins from the same DNA
sequence.
• Alternative splicing, in which the same pre-mRNA can be
spliced in more than one way to generate multiple mRNAs
that are translated into different amino acid sequences and
thus different proteins, is one form of alternative processing.
• Another method of alternative processing involves the use of
several 3′ cleavage sites, where the pre-mRNA comprises two
or more potential cleavage and polyadenylation sites.
• In the same pre-mRNA transcript, both alternative
splicing and multiple 3′ cleavage sites can exist.
• In multicellular eukaryotes, alternative processing of
pre-mRNAs is common.
• Researchers predict, that more than 90% of all human
genes undergo alternate splicing.
• The type of splicing also varies between human
tissues; compared to other tissues, the human brain
and liver tissues have more alternatively spliced RNA.
RNA editing:
• The coding sequence of an mRNA molecule is altered after
transcription in RNA editing, so that the protein has an amino
acid sequence that varies from that of the gene encoded.
• There were substitutions in some of the mRNA nucleotides in
some nuclear genes in mammalian cells and in some
mitochondrial genes in plant cells.
• More extensive RNA editing for certain mitochondrial genes in
trypanosome parasites has been found in the mRNA.
• More than 60 percent of the sequence is determined by RNA
editing in some of these organisms’mRNAs.
• In RNA sequences, a variety of mechanisms can bring
about changes.
• Molecules called guide RNAs (gRNAs) play a key role
in certain situations.
• gRNAs consist of sequences that are partly
complementary to pre-edited RNA segments.
• In these sequences, the two molecules goes through
base pairing.
• The mRNA undergoes cleavage after the mRNA is
anchored to the gRNA and nucleotides are inserted,
removed or altered according to the gRNA template
given.
• Enzymes bring about the conversion of the base in
other cases.
• For example, in humans, a gene is transcribed into
mRNA that encodes a lipid-transporting polypeptide
called apolipoprotein-B100, which is synthesized in
liver cells and has 4563 amino acids.
•By editing the apolipoprotein-B100 mRNA, a
truncated version of the protein called apolipoprotein-
B48 with only 2153 amino acids is synthesized in
intestinal cells.
•A cytosine base is deaminated by an enzyme in this
editing, transforming it into uracil.
•This conversion converts a codon that specifies the
glutamine amino acid into a stop codon that
terminates translation prematurely, resulting in the
protein being shortened.
Thank You

More Related Content

What's hot

R rna processing
R rna processingR rna processing
R rna processing
BanupriyaRajan1
 
TRANSCRIPTION IN EUKARYOTES
TRANSCRIPTION IN EUKARYOTES TRANSCRIPTION IN EUKARYOTES
TRANSCRIPTION IN EUKARYOTES
Rachana Choudhary
 
Transcription factors
Transcription factorsTranscription factors
Transcription factors
NehaliBuchade
 
5’ capping
5’ capping5’ capping
5’ capping
EmaSushan
 
Cromatin Remodeling
Cromatin RemodelingCromatin Remodeling
Cromatin Remodeling
Balaji Thorat
 
Site specific recombination
Site specific recombinationSite specific recombination
Site specific recombination
Roshan Parihar
 
Dna replication in eukaryotes
Dna replication in eukaryotesDna replication in eukaryotes
Dna replication in eukaryotes
Ahmad Raza
 
TRANSPOSABLE ELEMENTS
TRANSPOSABLE   ELEMENTSTRANSPOSABLE   ELEMENTS
TRANSPOSABLE ELEMENTS
seetugulia
 
Transcription in prokaryotes
Transcription in prokaryotesTranscription in prokaryotes
Transcription in prokaryotes
Kaayathri Devi
 
Trp operon
Trp operonTrp operon
Trp operon
Monika Uma Shankar
 
TRANSLATION
TRANSLATIONTRANSLATION
TRANSLATION
Surender Rawat
 
Tryptophan operon
Tryptophan operonTryptophan operon
Tryptophan operon
devadevi666
 
Translation in Prokaryotes and Eukaryotes
Translation  in Prokaryotes and Eukaryotes Translation  in Prokaryotes and Eukaryotes
Translation in Prokaryotes and Eukaryotes
Ikram Ullah
 
Molecular mechanism of antisense molecules
Molecular mechanism of antisense moleculesMolecular mechanism of antisense molecules
Molecular mechanism of antisense molecules
Prabhu Thirusangu
 
Transposable elements in Maize And Drosophila
Transposable elements in Maize And DrosophilaTransposable elements in Maize And Drosophila
Transposable elements in Maize And Drosophila
Subhradeep sarkar
 
RNA SPLICING
RNA SPLICINGRNA SPLICING
RNA SPLICING
manojjeya
 
Alternative splicing : mechanism and regulation
Alternative splicing : mechanism and regulationAlternative splicing : mechanism and regulation
Alternative splicing : mechanism and regulation
Smrutirekha Sahu
 
Site specific recombination
Site specific recombinationSite specific recombination
Site specific recombination
rahul manjunath
 
Dna replication in prokaryotes
Dna replication in prokaryotesDna replication in prokaryotes
Dna replication in prokaryotes
Fatima Parvez
 

What's hot (20)

R rna processing
R rna processingR rna processing
R rna processing
 
TRANSCRIPTION IN EUKARYOTES
TRANSCRIPTION IN EUKARYOTES TRANSCRIPTION IN EUKARYOTES
TRANSCRIPTION IN EUKARYOTES
 
Transcription factors
Transcription factorsTranscription factors
Transcription factors
 
Prokaryotic replication
Prokaryotic replicationProkaryotic replication
Prokaryotic replication
 
5’ capping
5’ capping5’ capping
5’ capping
 
Cromatin Remodeling
Cromatin RemodelingCromatin Remodeling
Cromatin Remodeling
 
Site specific recombination
Site specific recombinationSite specific recombination
Site specific recombination
 
Dna replication in eukaryotes
Dna replication in eukaryotesDna replication in eukaryotes
Dna replication in eukaryotes
 
TRANSPOSABLE ELEMENTS
TRANSPOSABLE   ELEMENTSTRANSPOSABLE   ELEMENTS
TRANSPOSABLE ELEMENTS
 
Transcription in prokaryotes
Transcription in prokaryotesTranscription in prokaryotes
Transcription in prokaryotes
 
Trp operon
Trp operonTrp operon
Trp operon
 
TRANSLATION
TRANSLATIONTRANSLATION
TRANSLATION
 
Tryptophan operon
Tryptophan operonTryptophan operon
Tryptophan operon
 
Translation in Prokaryotes and Eukaryotes
Translation  in Prokaryotes and Eukaryotes Translation  in Prokaryotes and Eukaryotes
Translation in Prokaryotes and Eukaryotes
 
Molecular mechanism of antisense molecules
Molecular mechanism of antisense moleculesMolecular mechanism of antisense molecules
Molecular mechanism of antisense molecules
 
Transposable elements in Maize And Drosophila
Transposable elements in Maize And DrosophilaTransposable elements in Maize And Drosophila
Transposable elements in Maize And Drosophila
 
RNA SPLICING
RNA SPLICINGRNA SPLICING
RNA SPLICING
 
Alternative splicing : mechanism and regulation
Alternative splicing : mechanism and regulationAlternative splicing : mechanism and regulation
Alternative splicing : mechanism and regulation
 
Site specific recombination
Site specific recombinationSite specific recombination
Site specific recombination
 
Dna replication in prokaryotes
Dna replication in prokaryotesDna replication in prokaryotes
Dna replication in prokaryotes
 

Similar to RNA Processing

Post transcriptional processing
Post transcriptional processingPost transcriptional processing
Post transcriptional processing
Ms.Anuja Mary Sabu
 
Protein synthesis
Protein synthesisProtein synthesis
Protein synthesis
Mehtab Hassan
 
Post transcriptional modifications
Post transcriptional modificationsPost transcriptional modifications
Post transcriptional modifications
Prasanna R Kovath
 
post transcriptional modifications
post transcriptional modificationspost transcriptional modifications
post transcriptional modifications
Nilandu Kumar
 
posttranscriptionalmodification-140721234932-phpapp01 (1).pdf
posttranscriptionalmodification-140721234932-phpapp01 (1).pdfposttranscriptionalmodification-140721234932-phpapp01 (1).pdf
posttranscriptionalmodification-140721234932-phpapp01 (1).pdf
MasihUllah11
 
protein translation
protein translationprotein translation
protein translationDr-HAMDAN
 
Group 6 - Post Transcriptional Modifications (RNA Splicng and ALternative Spl...
Group 6 - Post Transcriptional Modifications (RNA Splicng and ALternative Spl...Group 6 - Post Transcriptional Modifications (RNA Splicng and ALternative Spl...
Group 6 - Post Transcriptional Modifications (RNA Splicng and ALternative Spl...
NafeesaHanif1
 
Post transcriptional modification
Post transcriptional modificationPost transcriptional modification
Post transcriptional modification
Muhammed sadiq
 
2_2018_03_19!02_55_44_PM.pdf
2_2018_03_19!02_55_44_PM.pdf2_2018_03_19!02_55_44_PM.pdf
2_2018_03_19!02_55_44_PM.pdf
RajHardip
 
27 28 105 fa13 transcription and translation skel
27 28 105 fa13 transcription and translation skel27 28 105 fa13 transcription and translation skel
27 28 105 fa13 transcription and translation skelAfton Chase
 
transcription activators, repressors, & control RNA splicing, procesing and e...
transcription activators, repressors, & control RNA splicing, procesing and e...transcription activators, repressors, & control RNA splicing, procesing and e...
transcription activators, repressors, & control RNA splicing, procesing and e...
ranjithahb ranjithahbhb
 
protein synthesis
protein synthesisprotein synthesis
protein synthesis
Nawfal Aldujaily
 
Gene expression & protein synthesis
Gene expression & protein synthesisGene expression & protein synthesis
Gene expression & protein synthesis
ssuserc4adda
 
Biomol-Translation Eukaryote.pptx
Biomol-Translation Eukaryote.pptxBiomol-Translation Eukaryote.pptx
Biomol-Translation Eukaryote.pptx
FitriWidyaHandayani1
 
Translation Genetic code & Mutations.pdf
Translation Genetic code & Mutations.pdfTranslation Genetic code & Mutations.pdf
Translation Genetic code & Mutations.pdf
irfan350885
 
Subin cology
Subin cologySubin cology
Subin cology
maheshwari14
 
gene expression traditional methods
gene expression traditional methods gene expression traditional methods
gene expression traditional methods
Dr Dhavalkumar F. Chaudhary
 
Protein synthesis.
Protein synthesis.Protein synthesis.
Protein synthesis.
KrishnaSahu94
 

Similar to RNA Processing (20)

Post transcriptional processing
Post transcriptional processingPost transcriptional processing
Post transcriptional processing
 
Protein synthesis
Protein synthesisProtein synthesis
Protein synthesis
 
Post transcriptional modifications
Post transcriptional modificationsPost transcriptional modifications
Post transcriptional modifications
 
post transcriptional modifications
post transcriptional modificationspost transcriptional modifications
post transcriptional modifications
 
posttranscriptionalmodification-140721234932-phpapp01 (1).pdf
posttranscriptionalmodification-140721234932-phpapp01 (1).pdfposttranscriptionalmodification-140721234932-phpapp01 (1).pdf
posttranscriptionalmodification-140721234932-phpapp01 (1).pdf
 
protein translation
protein translationprotein translation
protein translation
 
Group 6 - Post Transcriptional Modifications (RNA Splicng and ALternative Spl...
Group 6 - Post Transcriptional Modifications (RNA Splicng and ALternative Spl...Group 6 - Post Transcriptional Modifications (RNA Splicng and ALternative Spl...
Group 6 - Post Transcriptional Modifications (RNA Splicng and ALternative Spl...
 
Post transcriptional modification
Post transcriptional modificationPost transcriptional modification
Post transcriptional modification
 
2_2018_03_19!02_55_44_PM.pdf
2_2018_03_19!02_55_44_PM.pdf2_2018_03_19!02_55_44_PM.pdf
2_2018_03_19!02_55_44_PM.pdf
 
27 28 105 fa13 transcription and translation skel
27 28 105 fa13 transcription and translation skel27 28 105 fa13 transcription and translation skel
27 28 105 fa13 transcription and translation skel
 
transcription activators, repressors, & control RNA splicing, procesing and e...
transcription activators, repressors, & control RNA splicing, procesing and e...transcription activators, repressors, & control RNA splicing, procesing and e...
transcription activators, repressors, & control RNA splicing, procesing and e...
 
protein synthesis
protein synthesisprotein synthesis
protein synthesis
 
Gene expression & protein synthesis
Gene expression & protein synthesisGene expression & protein synthesis
Gene expression & protein synthesis
 
Biomol-Translation Eukaryote.pptx
Biomol-Translation Eukaryote.pptxBiomol-Translation Eukaryote.pptx
Biomol-Translation Eukaryote.pptx
 
Translation Genetic code & Mutations.pdf
Translation Genetic code & Mutations.pdfTranslation Genetic code & Mutations.pdf
Translation Genetic code & Mutations.pdf
 
Subin cology
Subin cologySubin cology
Subin cology
 
gene expression traditional methods
gene expression traditional methods gene expression traditional methods
gene expression traditional methods
 
Protein Synthesis.pptx
Protein Synthesis.pptxProtein Synthesis.pptx
Protein Synthesis.pptx
 
Protein synthesis.
Protein synthesis.Protein synthesis.
Protein synthesis.
 
Microbial genetics lectures 7, 8, and 9
Microbial genetics lectures  7, 8, and 9Microbial genetics lectures  7, 8, and 9
Microbial genetics lectures 7, 8, and 9
 

More from Koppala RVS Chaitanya

Respirtory stimulants.pdf
Respirtory stimulants.pdfRespirtory stimulants.pdf
Respirtory stimulants.pdf
Koppala RVS Chaitanya
 
Nasal Decongestants.pdf
Nasal Decongestants.pdfNasal Decongestants.pdf
Nasal Decongestants.pdf
Koppala RVS Chaitanya
 
Expectorants and Antitussives.pdf
Expectorants and Antitussives.pdfExpectorants and Antitussives.pdf
Expectorants and Antitussives.pdf
Koppala RVS Chaitanya
 
Appeptite stimulants and suppresents.pdf
Appeptite stimulants and suppresents.pdfAppeptite stimulants and suppresents.pdf
Appeptite stimulants and suppresents.pdf
Koppala RVS Chaitanya
 
Digestants and Carminatives.pdf
Digestants and Carminatives.pdfDigestants and Carminatives.pdf
Digestants and Carminatives.pdf
Koppala RVS Chaitanya
 
THYROID HORMONES AND THYROID INHIBITORS.pdf
THYROID HORMONES AND THYROID INHIBITORS.pdfTHYROID HORMONES AND THYROID INHIBITORS.pdf
THYROID HORMONES AND THYROID INHIBITORS.pdf
Koppala RVS Chaitanya
 
CORTICOSTERIODS.pdf
CORTICOSTERIODS.pdfCORTICOSTERIODS.pdf
CORTICOSTERIODS.pdf
Koppala RVS Chaitanya
 
Anterior Pituitary Hormones.pdf
Anterior Pituitary Hormones.pdfAnterior Pituitary Hormones.pdf
Anterior Pituitary Hormones.pdf
Koppala RVS Chaitanya
 
Anti gout drugs.pdf
Anti gout drugs.pdfAnti gout drugs.pdf
Anti gout drugs.pdf
Koppala RVS Chaitanya
 
Anti Rheumatic drugs.pdf
Anti Rheumatic drugs.pdfAnti Rheumatic drugs.pdf
Anti Rheumatic drugs.pdf
Koppala RVS Chaitanya
 
Non Steroidal Anti inflammatory Drugs.pdf
Non Steroidal Anti inflammatory Drugs.pdfNon Steroidal Anti inflammatory Drugs.pdf
Non Steroidal Anti inflammatory Drugs.pdf
Koppala RVS Chaitanya
 
Histamine.pptx
Histamine.pptxHistamine.pptx
Histamine.pptx
Koppala RVS Chaitanya
 
PHARMACOLOGY EXPERIMENTS.pdf
PHARMACOLOGY EXPERIMENTS.pdfPHARMACOLOGY EXPERIMENTS.pdf
PHARMACOLOGY EXPERIMENTS.pdf
Koppala RVS Chaitanya
 
Antiplatelet drugs pharmacology.pdf
Antiplatelet drugs pharmacology.pdfAntiplatelet drugs pharmacology.pdf
Antiplatelet drugs pharmacology.pdf
Koppala RVS Chaitanya
 
Shock.pdf
Shock.pdfShock.pdf
Morphine Poisoning.pdf
Morphine Poisoning.pdfMorphine Poisoning.pdf
Morphine Poisoning.pdf
Koppala RVS Chaitanya
 
Barbiturate Poisoning.pdf
Barbiturate Poisoning.pdfBarbiturate Poisoning.pdf
Barbiturate Poisoning.pdf
Koppala RVS Chaitanya
 
CHRONOTHERAPY.pdf
CHRONOTHERAPY.pdfCHRONOTHERAPY.pdf
CHRONOTHERAPY.pdf
Koppala RVS Chaitanya
 
MONOCLONAL ANITBODIES.pdf
MONOCLONAL ANITBODIES.pdfMONOCLONAL ANITBODIES.pdf
MONOCLONAL ANITBODIES.pdf
Koppala RVS Chaitanya
 
Heavy Metal Poisoning.pdf
Heavy Metal Poisoning.pdfHeavy Metal Poisoning.pdf
Heavy Metal Poisoning.pdf
Koppala RVS Chaitanya
 

More from Koppala RVS Chaitanya (20)

Respirtory stimulants.pdf
Respirtory stimulants.pdfRespirtory stimulants.pdf
Respirtory stimulants.pdf
 
Nasal Decongestants.pdf
Nasal Decongestants.pdfNasal Decongestants.pdf
Nasal Decongestants.pdf
 
Expectorants and Antitussives.pdf
Expectorants and Antitussives.pdfExpectorants and Antitussives.pdf
Expectorants and Antitussives.pdf
 
Appeptite stimulants and suppresents.pdf
Appeptite stimulants and suppresents.pdfAppeptite stimulants and suppresents.pdf
Appeptite stimulants and suppresents.pdf
 
Digestants and Carminatives.pdf
Digestants and Carminatives.pdfDigestants and Carminatives.pdf
Digestants and Carminatives.pdf
 
THYROID HORMONES AND THYROID INHIBITORS.pdf
THYROID HORMONES AND THYROID INHIBITORS.pdfTHYROID HORMONES AND THYROID INHIBITORS.pdf
THYROID HORMONES AND THYROID INHIBITORS.pdf
 
CORTICOSTERIODS.pdf
CORTICOSTERIODS.pdfCORTICOSTERIODS.pdf
CORTICOSTERIODS.pdf
 
Anterior Pituitary Hormones.pdf
Anterior Pituitary Hormones.pdfAnterior Pituitary Hormones.pdf
Anterior Pituitary Hormones.pdf
 
Anti gout drugs.pdf
Anti gout drugs.pdfAnti gout drugs.pdf
Anti gout drugs.pdf
 
Anti Rheumatic drugs.pdf
Anti Rheumatic drugs.pdfAnti Rheumatic drugs.pdf
Anti Rheumatic drugs.pdf
 
Non Steroidal Anti inflammatory Drugs.pdf
Non Steroidal Anti inflammatory Drugs.pdfNon Steroidal Anti inflammatory Drugs.pdf
Non Steroidal Anti inflammatory Drugs.pdf
 
Histamine.pptx
Histamine.pptxHistamine.pptx
Histamine.pptx
 
PHARMACOLOGY EXPERIMENTS.pdf
PHARMACOLOGY EXPERIMENTS.pdfPHARMACOLOGY EXPERIMENTS.pdf
PHARMACOLOGY EXPERIMENTS.pdf
 
Antiplatelet drugs pharmacology.pdf
Antiplatelet drugs pharmacology.pdfAntiplatelet drugs pharmacology.pdf
Antiplatelet drugs pharmacology.pdf
 
Shock.pdf
Shock.pdfShock.pdf
Shock.pdf
 
Morphine Poisoning.pdf
Morphine Poisoning.pdfMorphine Poisoning.pdf
Morphine Poisoning.pdf
 
Barbiturate Poisoning.pdf
Barbiturate Poisoning.pdfBarbiturate Poisoning.pdf
Barbiturate Poisoning.pdf
 
CHRONOTHERAPY.pdf
CHRONOTHERAPY.pdfCHRONOTHERAPY.pdf
CHRONOTHERAPY.pdf
 
MONOCLONAL ANITBODIES.pdf
MONOCLONAL ANITBODIES.pdfMONOCLONAL ANITBODIES.pdf
MONOCLONAL ANITBODIES.pdf
 
Heavy Metal Poisoning.pdf
Heavy Metal Poisoning.pdfHeavy Metal Poisoning.pdf
Heavy Metal Poisoning.pdf
 

Recently uploaded

Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 

Recently uploaded (20)

Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 

RNA Processing

  • 2. Messenger RNA (mRNA) and its region • Messenger RNA operates as the template for protein synthesis. • Messenger RNA encodes genetic information from DNA as a transcript and translates the information to a ribosome and helps assemble amino acids in their proper order. • mRNA is directly transcribed from DNA, whereas in case of eukaryotes, a pre-mRNA is first transcribed from DNA and then processed to yield mature mRNA.
  • 3. Three main regions occur in both prokaryotic and eukaryotic mRNAs. 1. 5’ UTR: •The 5′ untranslated region (5′ UTR; also called the leader) is a nucleotide sequence at the 5′ end of the mRNA that does not encode any of amino acids. •In bacterial mRNA, this region consists of the consensus sequence termed as the Shine-Dalgarno sequence.
  • 4. •During translation, Shine-Dalgarno sequence serves as a ribosome binding site. This sequence is found approximately seven nucleotides upstream of the first codon that is translated into the amino acid, also termed as start codon. •In its 5′ untranslated region, eukaryotic mRNA has no equivalent consensus sequence. •Ribosomes bind to a modified 5′ end of mRNA in eukaryotic cells.
  • 5. 2. Protein coding region: •The next section of mRNA is the protein-coding region, containing the codons that describe the protein’s amino acid sequence. •The protein-coding region starts with a start codon and terminates with a stop codon.
  • 6. 3. 3’ UTR: •The 3′ untranslated region (trailer), a nucleotide sequence at the3′ end of the mRNA, is the last mRNA region and not translated into protein. •The 3′ UTR affects mRNA stability and the translation of the protein-coding sequence of the mRNA.
  • 7.
  • 8. Post-transcriptional modification in Eukaryotes • Transcription and translation take place concurrently in bacterial cells; when the 3′ end of an mRNA is undergoing transcription, ribosomes bind near the 5′ end to the Shine- Dalgarno sequence and begin translation. • Since transcription and translation are coupled, before protein synthesis, bacterial mRNA has little opportunity to be changed. • In contrast, in eukaryotic cells, transcription and translation are segregated both in time and space.
  • 9. •In the nucleus, transcription takes place while translation takes place in the cytoplasm; this separation offers a chance to modify eukaryotic RNA before translating it. •Indeed, after transcription, eukaryotic mRNA is altered extensively. •Changes are made to the RNA molecule’s 5′ end, the 3′ end, and protein coding portion. •Following are the examples of Post-transcriptional modification:
  • 10. 1. The 5 ‘Cap Addition: • One type of eukaryotic pre-mRNA modification is the addition of a structure called a 5 ‘cap at its 5’end. • At the 5’ end of the mRNA, the cap consists of an additional nucleotide and methyl groups (CH3) at the base of one or more nucleotides at the 5′ end of the newly inserted nucleotide and the 2′- OH group of sugar. • After transcription initiation, the insertion of the cap takes place quickly. • It is possible to represent the 5′ end of pre-mRNA as 5′-pppNpNpN, in which a ribonucleotide is represented by the letter ‘N‘ and a phosphate by ‘p‘.
  • 11.
  • 12. • One of these phosphate groups is removed shortly after the start of transcription and a guanine nucleotide is added. • A special 5′-5′ bond connects this guanine nucleotide to the pre mRNA, which is somewhat different from the normal 5′-3′ phosphodiester bond that binds all the other RNA nucleotides. • To the 5′ end, one or more methyl groups are added.
  • 13. • The first of these methyl groups is attached to the position 7 of the base of the terminal guanine nucleotide making the base 7-methyl guanine. • Next, in the second and third nucleotides, a methyl group may be attached to the 2′ position of the sugar. • Additional methyl groups can rarely be attached to the bases of the second and third nucleotides of pre- mRNA.
  • 14. 2. The Poly A tail addition: • The addition of 50 to 250 or more adenine nucleotides at the 3′ end, forming a poly(A) tail, is a second kind of modification to eukaryotic mRNA. • These nucleotides are not encoded in the DNA, but are inserted in a process called polyadenylation following transcription. • Many RNA polymerase II transcribed eukaryotic genes are transcribed well past the end of the coding sequence; much of the extra material is then cleaved at the3′ end and the poly(A) tail is inserted.
  • 15.
  • 16.
  • 17. •Sequences both upstream and downstream of the cleavage site are necessary for processing the3′ end of pre-mRNA. •Generally, downstream of the cleavage site is a sequence rich in uracil nucleotides. •On many mRNAs, the poly(A) tail confers stability, increasing the time during which the mRNA remains intact and available for translation. •The poly(A) tail also enhances the ribosome’s attachment to the mRNA.
  • 18. 3. RNA splicing: • The removal of introns by RNA splicing is the other major type of eukaryotic pre-mRNA modification. • Before the RNA moves to the cytoplasm, this modification takes place in the nucleus. • The presence of three sequences in the intron is required for splicing.
  • 19.
  • 20. •One end of the intron is referred to as the 5′ splice site, and the other end is the 3′ splice site. •Most introns begin with GU in pre-mRNAs and end with AG. •The third sequence that is necessary for splicing is present at the branch point, which is an adenine nucleotide that is situated 18-40 nucleotides upstream of the 3′ splice site.
  • 21. • Splicing occurs within a large structure called the spliceosome, which is one of the largest and most complex of all molecular complexes. • Five RNA molecules (U1, U2, U4, U5, and U6) and almost 300 proteins form the spliceosome. • Small nuclear RNAs (snRNAs) ranging in length from 107 to 210 nucleotides are the RNA components; these snRNAs are associated with proteins to form small particles of ribonucleoprotein.
  • 22. Process of RNA splicing: • An intron is between an upstream exon (exon1) and a downstream exon (exon 2) before splicing takes place. • In two distinct stages, pre-mRNA is spliced. • The pre-mRNA is cut at the 5 ‘splice site in the first stage of splicing. • This cut frees exon 1 from the intron, and the intron’s 5′ end connects to the branch point; that is, the intron folds back on itself, creating a structure called a lariat.
  • 23. • In this reaction, via a trans-esterification reaction, the guanine nucleotide in the consensus sequence at the 5′ splice site binds with the adenine nucleotide at the branch stage. • To the cytoplasm, where it is translated, the mature mRNA consisting of the exons spliced together is exported. • A cut is made at the3′ splice site in the second step of RNA splicing and, simultaneously, the3′ end of exon 1 is covalently connected (spliced) to the5′ end of exon 2.
  • 24. • It releases the intron as a lariat. • When the bond splits at the branch stage, the intron becomes linear and is then quickly degraded by nuclear enzymes. • To the cytoplasm, where it is translated, the mature mRNA consisting of the exons spliced together is exported.
  • 25. Alternative processing pathways for RNA splicing: • In order to generate alternative forms of mRNA, a single pre- mRNA is processed in various ways, resulting in the development of various proteins from the same DNA sequence. • Alternative splicing, in which the same pre-mRNA can be spliced in more than one way to generate multiple mRNAs that are translated into different amino acid sequences and thus different proteins, is one form of alternative processing. • Another method of alternative processing involves the use of several 3′ cleavage sites, where the pre-mRNA comprises two or more potential cleavage and polyadenylation sites.
  • 26.
  • 27. • In the same pre-mRNA transcript, both alternative splicing and multiple 3′ cleavage sites can exist. • In multicellular eukaryotes, alternative processing of pre-mRNAs is common. • Researchers predict, that more than 90% of all human genes undergo alternate splicing. • The type of splicing also varies between human tissues; compared to other tissues, the human brain and liver tissues have more alternatively spliced RNA.
  • 28. RNA editing: • The coding sequence of an mRNA molecule is altered after transcription in RNA editing, so that the protein has an amino acid sequence that varies from that of the gene encoded. • There were substitutions in some of the mRNA nucleotides in some nuclear genes in mammalian cells and in some mitochondrial genes in plant cells. • More extensive RNA editing for certain mitochondrial genes in trypanosome parasites has been found in the mRNA. • More than 60 percent of the sequence is determined by RNA editing in some of these organisms’mRNAs.
  • 29.
  • 30.
  • 31. • In RNA sequences, a variety of mechanisms can bring about changes. • Molecules called guide RNAs (gRNAs) play a key role in certain situations. • gRNAs consist of sequences that are partly complementary to pre-edited RNA segments. • In these sequences, the two molecules goes through base pairing.
  • 32. • The mRNA undergoes cleavage after the mRNA is anchored to the gRNA and nucleotides are inserted, removed or altered according to the gRNA template given. • Enzymes bring about the conversion of the base in other cases. • For example, in humans, a gene is transcribed into mRNA that encodes a lipid-transporting polypeptide called apolipoprotein-B100, which is synthesized in liver cells and has 4563 amino acids.
  • 33. •By editing the apolipoprotein-B100 mRNA, a truncated version of the protein called apolipoprotein- B48 with only 2153 amino acids is synthesized in intestinal cells. •A cytosine base is deaminated by an enzyme in this editing, transforming it into uracil. •This conversion converts a codon that specifies the glutamine amino acid into a stop codon that terminates translation prematurely, resulting in the protein being shortened.